An intraluminal medical device comprises a stent having a coating applied to at least part of an interior surface, an exterior surface, or both. The coating comprises a sustained release formulation of a combination of pharmaceutical compounds dispersed within a biologically tolerated polymer composition. The choice of the combination of pharmaceutical compounds are intended to reduce neointimal hyperplasia restenosis.

 
Web www.patentalert.com

< Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms

> Hair sustaining formulation

~ 00444